Serum Amyloid a Low-Density Lipoprotein Levels and Smoking Status in Obese Japanese Patients

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of International Medical Research

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/147323001103900536PMID 22117994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The potential of serum amyloid A–LDL as a novel biomarker for cardiovascular disease risk

  2010cited by this paper
• Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers.

  2010cited by this paper
• A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome.

  2009cited by this paper
• Molecular and biochemical changes of the cardiovascular system due to smoking exposure.

  2009cited by this paper
• Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review.

  2008cited by this paper
• Smoking and low serum testosterone associates with high concentration of oxidized LDL

  2008cited by this paper
• Impact of smoking cessation and lifetime exposure on C-reactive protein.

  2008cited by this paper
• Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers.

  2006cited by this paper
• The pathophysiology of cigarette smoking and cardiovascular disease: an update.

  2004cited by this paper
• Increased serum iron may contribute to enhanced oxidation of low-density lipoprotein in smokers in part through changes in lipoxygenase and catalase.

  2004cited by this paper
• Effect of nicotine and cotinine on the susceptibility to in vitro oxidation of LDL in healthy non smokers and smokers.

  1998cited by this paper
• Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate.

  1998cited by this paper
• Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease.

  1997cited by this paper
• Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers.

  1996cited by this paper
• Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis.

  1996cited by this paper
• Smoking influences the atherogenic potential of low-density lipoprotein

  1992cited by this paper
• Alteration of plasma low density lipoprotein from smokers.

  1990cited by this paper

• Aqueous humor perturbations in chronic smokers: a proteomic study

  2024cites this paper
• LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery

  2023cites this paper
• Structural studies of a serum amyloid A octamer that is primed to scaffold lipid nanodiscs

  2023cites this paper
• Effects of Smoking on Inflammatory-Related Cytokine Levels in Human Serum

  2022cites this paper
• High-Density Lipoproteins and Serum Amyloid A (SAA)

  2021cites this paper
• Role of serum amyloid A in atherosclerosis.

  2019cites this paper
• The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan

  2018cites this paper
• Serum Amyloid A Is an Exchangeable Apolipoprotein

  2018cites this paper
• Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation

  2016cites this paper
• Analysis of low‐density lipoprotein‐associated proteins using the method of digitized native protein mapping

  2016cites this paper
• Effect of Smoking on Serum Amyloid A-Low Density Lipoprotein in Sprague Dawley Rats

  2015cites this paper
• Elimination of advanced glycation end products by double filtration plasmapheresis

  2014cites this paper
• An update on serum amyloid A–LDL and its potential use for dyslipidemic patients receiving lipid-modulating treatment

  2013cites this paper
• Study of Effectiveness of Prevention by Double Filtration Plasmapheresis ( DFPP ) Against Arteriosclerotic Disease : Removal of Oxidized LDL-cholesterol and Pentosidine by DFPP

  2013cites this paper